ASX - By Stock
|
STK |
Re:
Stk General
|
|
bmfjch
|
924 |
314K |
6 |
23/04/24 |
23/04/24 |
ASX - By Stock
|
924
|
314K
|
6
|
|
ASX - By Stock
|
STK |
Re:
Ann: Excellent RC Drill Results from Marwari
|
|
bmfjch
|
98 |
40K |
4 |
18/12/23 |
18/12/23 |
ASX - By Stock
|
98
|
40K
|
4
|
|
ASX - By Stock
|
STK |
Re:
Ann: Aircore drilling extends Marwari structure 400m south
|
|
bmfjch
|
16 |
6.8K |
4 |
30/11/23 |
30/11/23 |
ASX - By Stock
|
16
|
6.8K
|
4
|
|
ASX - By Stock
|
KZA |
Re:
Option 2 vs 3
|
|
bmfjch
|
71 |
18K |
1 |
21/10/23 |
21/10/23 |
ASX - By Stock
|
71
|
18K
|
1
|
|
ASX - By Stock
|
KZA |
Re:
Option 2 vs 3
|
|
bmfjch
|
71 |
18K |
4 |
21/10/23 |
21/10/23 |
ASX - By Stock
|
71
|
18K
|
4
|
|
ASX - By Stock
|
KZA |
Re:
Ann: Kazia announces change to Board of Directors
|
|
bmfjch
|
20 |
6.5K |
6 |
11/08/23 |
11/08/23 |
ASX - By Stock
|
20
|
6.5K
|
6
|
|
ASX - By Stock
|
RTR |
Re:
Ann: Quarterly Activities/Appendix 5B Cash Flow Report
|
|
bmfjch
|
5 |
2.7K |
5 |
01/08/23 |
01/08/23 |
ASX - By Stock
|
5
|
2.7K
|
5
|
|
ASX - By Stock
|
KZA |
Re:
Ann: Appointment of Dr John Friend as Managing Director
|
|
bmfjch
|
4 |
1.7K |
1 |
01/08/23 |
01/08/23 |
ASX - By Stock
|
4
|
1.7K
|
1
|
|
ASX - By Stock
|
KZA |
Re:
Ann: Paxalisib receives Fast Track Designation from US FDA
|
|
bmfjch
|
42 |
12K |
3 |
11/07/23 |
11/07/23 |
ASX - By Stock
|
42
|
12K
|
3
|
|
ASX - By Stock
|
KZA |
Re:
Ann: Paxalisib receives Fast Track Designation from US FDA
|
|
bmfjch
|
42 |
12K |
0 |
11/07/23 |
11/07/23 |
ASX - By Stock
|
42
|
12K
|
0
|
|
ASX - By Stock
|
KZA |
Re:
Ann: Paxalisib receives Fast Track Designation from US FDA
|
|
bmfjch
|
42 |
12K |
6 |
10/07/23 |
10/07/23 |
ASX - By Stock
|
42
|
12K
|
6
|
|
ASX - By Stock
|
KZA |
Re:
Ann: Paxalisib receives Fast Track Designation from US FDA
|
|
bmfjch
|
42 |
12K |
4 |
09/07/23 |
09/07/23 |
ASX - By Stock
|
42
|
12K
|
4
|
|
ASX - By Stock
|
KZA |
Re:
Ann: Paxalisib receives Fast Track Designation from US FDA
|
|
bmfjch
|
42 |
12K |
2 |
08/07/23 |
08/07/23 |
ASX - By Stock
|
42
|
12K
|
2
|
|
ASX - By Stock
|
KZA |
Re:
DIPG Panel Discussion
|
|
bmfjch
|
103 |
38K |
7 |
04/07/23 |
04/07/23 |
ASX - By Stock
|
103
|
38K
|
7
|
|
ASX - By Stock
|
KZA |
Re:
Ann: Kazia Corporate Update and Corporate Presentation
|
|
bmfjch
|
27 |
7.7K |
4 |
27/06/23 |
27/06/23 |
ASX - By Stock
|
27
|
7.7K
|
4
|
|
ASX - By Stock
|
KZA |
Re:
High Quality Research-Non Cancer Disease
|
|
bmfjch
|
34 |
11K |
6 |
06/06/23 |
06/06/23 |
ASX - By Stock
|
34
|
11K
|
6
|
|
ASX - By Stock
|
KZA |
Re:
High Quality Research-Non Cancer Disease
|
|
bmfjch
|
34 |
11K |
4 |
06/06/23 |
06/06/23 |
ASX - By Stock
|
34
|
11K
|
4
|
|
ASX - By Stock
|
ZNC |
Re:
Ann: REE Project Portfolio Conditional Divestment & Joint Venture
|
|
bmfjch
|
10 |
3.6K |
3 |
10/05/23 |
10/05/23 |
ASX - By Stock
|
10
|
3.6K
|
3
|
|
ASX - By Stock
|
KZA |
Re:
Ann: Executive Leadership changes - Dr John Friend appointed CEO
|
|
bmfjch
|
55 |
17K |
3 |
08/05/23 |
08/05/23 |
ASX - By Stock
|
55
|
17K
|
3
|
|
ASX - By Stock
|
ZNC |
Re:
Company Responce
|
|
bmfjch
|
13 |
4.6K |
2 |
04/05/23 |
04/05/23 |
ASX - By Stock
|
13
|
4.6K
|
2
|
|
ASX - By Stock
|
ZNC |
Re:
Company Responce
|
|
bmfjch
|
13 |
4.6K |
3 |
04/05/23 |
04/05/23 |
ASX - By Stock
|
13
|
4.6K
|
3
|
|
ASX - By Stock
|
KZA |
Re:
Ann: EVT801 preclinical data published
|
|
bmfjch
|
47 |
12K |
10 |
03/12/22 |
03/12/22 |
ASX - By Stock
|
47
|
12K
|
10
|
|
ASX - By Stock
|
KZA |
Re:
Ann: Kazia Corporate Deck
|
|
bmfjch
|
24 |
6.0K |
5 |
20/01/22 |
20/01/22 |
ASX - By Stock
|
24
|
6.0K
|
5
|
|
ASX - By Stock
|
KZA |
Re:
SNO 26th Annual Meeting
|
|
bmfjch
|
123 |
35K |
2 |
23/11/21 |
23/11/21 |
ASX - By Stock
|
123
|
35K
|
2
|
|
ASX - By Stock
|
KZA |
Re:
KZA Media Thread
|
|
bmfjch
|
2.0K |
618K |
9 |
14/11/21 |
14/11/21 |
ASX - By Stock
|
2.0K
|
618K
|
9
|
|
ASX - By Stock
|
KZA |
Re:
KZA Media Thread
|
|
bmfjch
|
2.0K |
618K |
6 |
04/11/21 |
04/11/21 |
ASX - By Stock
|
2.0K
|
618K
|
6
|
|
ASX - By Stock
|
KZA |
Re:
KZA Media Thread
|
|
bmfjch
|
2.0K |
618K |
12 |
31/10/21 |
31/10/21 |
ASX - By Stock
|
2.0K
|
618K
|
12
|
|
ASX - By Stock
|
KZA |
Re:
KZA Media Thread
|
|
bmfjch
|
2.0K |
618K |
3 |
31/10/21 |
31/10/21 |
ASX - By Stock
|
2.0K
|
618K
|
3
|
|
ASX - By Stock
|
KZA |
Re:
Ann: Quarterly Activities/Appendix 4C Cash Flow Report
|
|
bmfjch
|
27 |
6.3K |
12 |
29/10/21 |
29/10/21 |
ASX - By Stock
|
27
|
6.3K
|
12
|
|
ASX - By Stock
|
KZA |
Re:
KZA Media Thread
|
|
bmfjch
|
2.0K |
618K |
2 |
22/10/21 |
22/10/21 |
ASX - By Stock
|
2.0K
|
618K
|
2
|
|
ASX - By Stock
|
KZA |
Re:
AACR Virtual Special Conference: Brain Cancer
|
|
bmfjch
|
3 |
1.2K |
6 |
16/10/21 |
16/10/21 |
ASX - By Stock
|
3
|
1.2K
|
6
|
|
ASX - By Stock
|
KZA |
Re:
AACR Virtual Special Conference: Brain Cancer
|
|
bmfjch
|
3 |
1.2K |
4 |
16/10/21 |
16/10/21 |
ASX - By Stock
|
3
|
1.2K
|
4
|
|
ASX - By Stock
|
KZA |
Re:
SNO 26th Annual Meeting
|
|
bmfjch
|
123 |
35K |
3 |
16/10/21 |
16/10/21 |
ASX - By Stock
|
123
|
35K
|
3
|
|
ASX - By Stock
|
KZA |
Re:
SNO 26th Annual Meeting
|
|
bmfjch
|
123 |
35K |
4 |
16/10/21 |
16/10/21 |
ASX - By Stock
|
123
|
35K
|
4
|
|
ASX - By Stock
|
KZA |
Re:
KZA Media Thread
|
|
bmfjch
|
2.0K |
618K |
5 |
15/10/21 |
15/10/21 |
ASX - By Stock
|
2.0K
|
618K
|
5
|
|
ASX - By Stock
|
KZA |
Re:
PI3K/mtor inhibition effects against COVID-19
|
|
bmfjch
|
7 |
2.5K |
8 |
10/10/21 |
10/10/21 |
ASX - By Stock
|
7
|
2.5K
|
8
|
|
ASX - By Stock
|
KZA |
Re:
How does GBM AGILE work?
|
|
bmfjch
|
73 |
24K |
10 |
04/10/21 |
04/10/21 |
ASX - By Stock
|
73
|
24K
|
10
|
|
ASX - By Stock
|
KZA |
Re:
Interview with Dr Matt Dun on DIPG research and GDC-0084
|
|
bmfjch
|
81 |
24K |
4 |
28/09/21 |
28/09/21 |
ASX - By Stock
|
81
|
24K
|
4
|
|
ASX - By Stock
|
KZA |
Re:
Sydney Cancer conference July 9-10
|
|
bmfjch
|
5 |
1.6K |
6 |
09/09/21 |
09/09/21 |
ASX - By Stock
|
5
|
1.6K
|
6
|
|
ASX - By Stock
|
KZA |
Re:
Sydney Cancer conference July 9-10
|
|
bmfjch
|
5 |
1.6K |
4 |
09/09/21 |
09/09/21 |
ASX - By Stock
|
5
|
1.6K
|
4
|
|
ASX - By Stock
|
KZA |
Re:
Ann: Kazia's EVT801 phase I trial receives regulatory approval
|
|
bmfjch
|
6 |
2.3K |
10 |
02/09/21 |
02/09/21 |
ASX - By Stock
|
6
|
2.3K
|
10
|
|
ASX - By Stock
|
KZA |
Re:
KZA Media Thread
|
|
bmfjch
|
2.0K |
618K |
16 |
28/08/21 |
28/08/21 |
ASX - By Stock
|
2.0K
|
618K
|
16
|
|
ASX - By Stock
|
KZA |
Re:
Ann: Kazia corporate presentation
|
|
bmfjch
|
27 |
7.7K |
7 |
23/08/21 |
23/08/21 |
ASX - By Stock
|
27
|
7.7K
|
7
|
|
ASX - By Stock
|
KZA |
Re:
Ann: Kazia corporate presentation
|
|
bmfjch
|
27 |
7.7K |
11 |
21/08/21 |
21/08/21 |
ASX - By Stock
|
27
|
7.7K
|
11
|
|
ASX - By Stock
|
KZA |
Re:
Interview with Dr Matt Dun on DIPG research and GDC-0084
|
|
bmfjch
|
81 |
24K |
9 |
19/08/21 |
19/08/21 |
ASX - By Stock
|
81
|
24K
|
9
|
|
ASX - By Stock
|
KZA |
Re:
KZA Media Thread
|
|
bmfjch
|
2.0K |
618K |
7 |
14/08/21 |
14/08/21 |
ASX - By Stock
|
2.0K
|
618K
|
7
|
|
ASX - By Stock
|
KZA |
Re:
Interview with Dr Matt Dun on DIPG research and GDC-0084
|
|
bmfjch
|
81 |
24K |
13 |
01/08/21 |
01/08/21 |
ASX - By Stock
|
81
|
24K
|
13
|
|
ASX - By Stock
|
WGO |
Re:
Ann: WE-5 Commences Clean Up
|
|
bmfjch
|
299 |
71K |
6 |
30/07/21 |
30/07/21 |
ASX - By Stock
|
299
|
71K
|
6
|
|
ASX - By Stock
|
KZA |
Re:
Interview with Dr Matt Dun on DIPG research and GDC-0084
|
|
bmfjch
|
81 |
24K |
10 |
29/07/21 |
29/07/21 |
ASX - By Stock
|
81
|
24K
|
10
|
|
ASX - By Stock
|
WGO |
Re:
Ann: Becoming a substantial holder from STX
|
|
bmfjch
|
85 |
23K |
6 |
20/07/21 |
20/07/21 |
ASX - By Stock
|
85
|
23K
|
6
|
|